Individualized Choices in Antiretroviral Therapy: Present and Future

Join us for this interactive case-based symposium to hear expert faculty discuss patient-centered ART. Discussion will include considerations for individual patient factors and appropriate patient counseling regarding the anticipated clinical role of new and investigational ART regimens in individualized care.

This event will only be available to registered participants of EACS 2021. If you have registered for EACS 2021 and would like to participate, please proceed to the in-person program or to the conference online portal provided by the organizers. If you haven’t registered, you can register for the conference here.


  • Overview of Current Patient-Centered ART (15 min)
    Chloe Orkin, MBChB, FRCP, MD
  • Case-Based Discussion: Putting Individualized Care Into Practice (45 min)
    Chloe Orkin, MBChB, FRCP, MD, Jean-Michel Molina, MD, PhD, Cristina Mussini, MD
  • Future ART: Closing the Remaining Gaps (10 min)
    Jean-Michel MolinaMD, PhD
  • Question and Answers (20 min)


Date / Time
Event Details


Program Director
Chloe Orkin, MBChB, FRCP, MD

Professor of HIV
Queen Mary, University of London
Consultant Physician
Lead for HIV Research
Barts Health NHS Trust
The Royal London Hospital
London, United Kingdom

Jean-Michel Molina, MD, PhD

Head of the Department of Infectious Diseases
Saint-Louis Hospital, Assistance-Publique Hôpitaux de Paris
Paris, France
Professor of Infectious Diseases
University of Paris
Paris, France

Cristina Mussini, MD

Head of Department of Infectious Diseases and Tropical Medicine
Full Professor of Infectious Diseases

Infectious Diseases Clinics, University Hospital
University of Modena and Reggio Emilia
Modena, Italy

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal individualized care for patients with HIV today and in the future.

Target Audience
This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for patients with HIV.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Apply the results of recent clinical studies and evolving treatment guidelines on the timing and choice of first-line ART and switch strategies and managing treatment-experienced patients with HIV
  • Integrate individual patient factors such as drug–drug interactions, comorbidities, pregnancy status, adherence, and dosing preferences when selecting optimal ART
  • Appropriately counsel patients regarding the anticipated clinical role of new and investigational ART regimens in individualized care


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. 

Live Meeting UAN: JA4008176-0000-21-176-L02-P

Live Webinar UAN: JA4008176-0000-21-177-L02-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.